Filters
on 14 Apr 2022
ASTELLAS PHARMA INC.
2179738 · 14 Apr 2022
009
Class 009
Computer & Software Products & Electrical & Scientific Products
Computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, PDAs and mobile phones, namely, software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease including the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers.
Computer application software for use with web-based platforms and mob...
on 20 Sep 2023
SYNTHORX INC.
2066757 · 10 Jul 2020
005
Class 005
Pharmaceutical Products
Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, oncology including immuno-oncology, for the treatment of cardiovascular and metabolic diseases, and for the treatment of infectious diseases, namely, respiratory infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; modified protein to be used in connection with a variety of therapeutic areas, namely protein arrays for medical diagnostic purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension
042
Class 042
Computer & Software Services & Scientific Services
Medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents
Protein therapeutics expressed, prepared or manufactured using a semi-...
on 09 Aug 2024
SYNTHORX INC.
1945232 · 08 Feb 2019
005
Class 005
Pharmaceutical Products
Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology including immuno-oncology, cardiovascular diseases, and metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, and infectious diseases, namely, urinary tract infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, including rheumatism, oncology including immuno-oncology, pulmonology, namely, respiratory diseases, gastroenterology, endocrine diseases, namely, glucagonoma, dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, urology, gynecology, namely, disorders relating to sexual reproduction and fertility, infectiology, namely, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, and geriatric diseases, namely, arthritis, osteoporosis, Dementia, Alzheimer's Disease, and Parkinson's Disease; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, including rheumatism, oncology including immuno-oncology, pulmonology, namely, respiratory diseases, gastroenterology, endocrine diseases, namely, glucagonoma, dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, urology, gynecology, namely, disorders relating to sexual reproduction and fertility, infectiology, namely, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, and geriatric diseases, namely, arthritis, osteoporosis, Dementia, Alzheimer's Disease, and Parkinson's Disease.
042
Class 042
Computer & Software Services & Scientific Services
Medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents.
Protein therapeutics expressed, prepared or manufactured using a semi-...
on 20 Feb 2020
SYNDEVRX INC.
1857954 · 18 Sep 2017
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cancer and metabolic disorders, namely hyperinsulinemia, hyperglycemia, hyperleptinemia, hypoadiponectinemia, type 2 diabetes, obesity, metabolic syndrome, pre-diabetes and rheumatoid arthritis.
Pharmaceutical preparations for the treatment of cancer and metabolic ...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Synthorx inc.. (2)
Anuvia plant nutrients holdings inc.. (1)
Astellas pharma inc.. (1)
Syndevrx inc.. (1)
Categories
Class 5 (3)
Class 42 (2)
Class 1 (1)
Class 9 (1)
Correspondents
Smart & biggar lp (2)
Baker & mckenzie llp (1)
Cpst intellectual property inc.. (1)
Mcmillan llp (1)
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1